CogRX: 1st Alzheimer’s Patient Dosed in Clinical Trial of Amyloid Beta ‘Displacer’ click here By John Harbison|2017-02-22T10:36:42-08:00November 23, 2016|Tech Coast Angels Portfolio Companies in the Press|Comments Off on CogRX: 1st Alzheimer’s Patient Dosed in Clinical Trial of Amyloid Beta ‘Displacer’ Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
